In this episode, we hear from Nate Beyor, managing director and partner of BCG healthcare. We dive into many topics around digital therapeutics and get a bird's eye view across BCG's customer base.

In this episode, we cover:

New company creation: large company spin-outs vs entrepreneurs 

What it takes to build a team that can take a digital therapeutic to market

Why build rather than buy a new DTx

Approaching medical pharma clients vs approaching smaller DTx companies

Go to market strategy and value creation: Standalone vs Drug+

Embedding clinical decision support into workflows


Guest Links and Resources:

Connect with Nate Beyor on: LinkedIn


Visit: www.bcg.com/


Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn


Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn


Connect with YourCoach.health: Website | Twitter


Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App


HealthXL: Website | Twitter | Join an Event




Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Ver todos los episodios